A longitudinal seroconversion panel shows anti-SARS-CoV-2 antibody levels up to 6.5 months after vaccination with mRNA-1273 (Moderna)
Francisco Belda, Oscar Mora, Rebecca Christie, Michael Crowley
doi: https://doi.org/10.1101/2022.01.25.22269762
Francisco Belda
1Research and Development, Bio Supplies Division, Grifols, 08174 Sant Cugat del Vallès (Barcelona), Spain
Oscar Mora
1Research and Development, Bio Supplies Division, Grifols, 08174 Sant Cugat del Vallès (Barcelona), Spain
Rebecca Christie
2Access Biologicals, Vista, CA 92081, USA
Michael Crowley
2Access Biologicals, Vista, CA 92081, USA
Article usage
Posted January 28, 2022.
A longitudinal seroconversion panel shows anti-SARS-CoV-2 antibody levels up to 6.5 months after vaccination with mRNA-1273 (Moderna)
Francisco Belda, Oscar Mora, Rebecca Christie, Michael Crowley
medRxiv 2022.01.25.22269762; doi: https://doi.org/10.1101/2022.01.25.22269762
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)